2 recruiting, 1 active not recruiting, 1 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Proton Collaborative Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy Proton Therapy - Breast Cancer | Phase 3 | Recruiting | Proton Collaborative Group | 276 | 2024-03-21 | 2026-09-29 |
| External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer Luteinizing hormone-releasing hormone (LHRH), Docetaxel, Conformal Radiation Therapy (RT) - Prostate Cancer | Phase 2 / Phase 3 | Terminated | Proton Collaborative Group | 2 | 2012-07-01 | 2016-03-14 |
| Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer Radiation, Androgen Suppression Therapy - Prostate Cancer | Phase 3 | Recruiting | Proton Collaborative Group | 192 | 2012-01-01 | 2026-09-29 |
| Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer Proton Radiation Hypofractionation, Proton Radiation Standard Fractionation - Prostate Cancer | Phase 3 | Active not recruiting | Proton Collaborative Group | 150 | 2010-11-01 | 2026-09-29 |
Prostatic Neoplasms (3) · Breast Neoplasms (1) · Neoplasms (1)
Goserelin (2) · Leuprolide (2) · Proton Therapy (2) · Buserelin (1) · Docetaxel (1) · Gonadotropin-Releasing Hormone (1) · Radiation (1) · Radiotherapy, Intensity-Modulated (1) · Triptorelin Pamoate (1) · luprolide acetate gel depot (1)
United States (4)
Carlos Vargas, MD (3) · Isabelle Choi, MD (1)